triclosan

Small moleculeapproved

Approved

Jul 11, 1997

Triclosan was used as a hospital scrub in the 1970s. Since then, it has expanded commercially and is now prevalent in soaps (0.10-1.00%), shampoos, deodorants, toothpastes, mouth washes, cleaning supplies and pesticides. It is part of consumer products, including kitchen utensils, toys, bedding, socks and trash bags. In healthcare, triclosan is used in surgical scrubs and hand washes. Use in surgical units is effective with a minimum contact time of approximately two minutes. More recently, showering with 2% triclosan has become a recommended regimen in surgical units for the decolonization of patients whose skin carries methicillin-resistant Staphylococcus aureus (MRSA). Triclosan is also used in the coatings for some surgical sutures. Triclosan has been employed as a selective agent in molecular cloning. At high concentrations, triclosan acts as a biocide with multiple cytoplasmic and membrane targets. However, at the lower concentrations seen in commercial products, triclosan appears bacteriostatic, and it targets bacteria primarily by inhibiting fatty acid synthesis. Triclosan binds to bacterial enoyl-acyl carrier protein reductase (ENR) enzyme, which is encoded by the gene FabI. This binding increases the enzyme's affinity for nicotinamide adenine dinucleotide (NAD+). This results in the formation of a stable, ternary complex of ENR-NAD+-triclosan, which is unable to participate in fatty acid synthesis. Fatty acids are necessary for building and reproducing cell membranes. Humans do not have an ENR enzyme and thus are not affected. — NCATS

Clinical trial activity

44 trials · 24 clinical orgs · 1 marketing orgs

Phase 1
0
Phase 2
26
Phase 3
25
Phase 4
13

Earliest trial started Nov 1, 2000 (NCT00763165)

Timeline

1990s

  1. Jul 11, 1997

    Colgate Palmolive — Earliest FDA Approval

  2. Jul 11, 1997

    Colgate Palmolive — NDA Secondary Org

  3. Jul 11, 1997

    Colgate Palmolive — NDA Organization

2000s

  1. Jan 1, 2000

    Colgate Palmolive — Earliest Phase 3 Sponsor(trial)

  2. Jan 1, 2007

    Colgate Palmolive — Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Combination products

Approval history

  • approvedJul 11, 1997

Chemistry & pharmacology

Loading structure…

SMILES

OC1=CC(Cl)=CC=C1OC2=CC=C(Cl)C=C2Cl
Mol. weight
289.542 g/mol
Lipinski Ro5
1 violation(s)
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No
Delivery
Topical
Availability
Discontinued

Oral

No

Parenteral

No

Topical

Yes

Sources

Also known as

  • 2,4,4'-trichloro-2'-hydroxydiphenyl ether
  • 2,4,4'-trichloro-2'-hydroxydiphenyl ether
  • 5-chloro-2-(2,4-dichloro-phenoxy)-phenol
  • 5-chloro-2-(2,4-dichloro-phenoxy)-phenol
  • aquasept
  • aquasept
  • innoxa
  • manusept
  • manusept
  • skinsan
  • stri-dex cleansing bar
  • stri-dex cleansing bar
  • stri-dex face wash
  • stri-dex face wash
  • tegusept
  • triclosan
  • triclosan
  • triclosan
  • triclosan
  • triclosan
  • triclosan
  • triclosan
  • triclosan
  • triclosanum
  • triclosanum

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05330650Phase 4Nov 1, 2020Ben Arous Hospital, Tunis, Tunisia, Tunis University
NCT04538365Phase 4Oct 1, 2020Centro Ortopedico y Quirurgico del Pie, Universidad Complutense de Madrid
NCT04256824Phase 4Feb 10, 2020Al Safwa Hospital, Al Zohour Hospital, ClinAmygate, Minia University, Misr University for Science and Technology, MSKMC Univeristy Hospital
NCT04255927Phase 4Feb 8, 2020Al Safwa Hospital, Cairo University, ClinAmygate, Misr University for Science and Technology
NCT03659344N/ASep 1, 2016Shahid Beheshti University of Medical Sciences, Shiraz University
NCT03642353Phase 4Jan 30, 2016University of Campinas
NCT02670135Phase 4Jun 1, 2015Colgate Palmolive
NCT02193165Phase 3Jul 1, 2014Colgate Palmolive
NCT02360995Phase 4Jun 1, 2014Colgate Palmolive, Loma Linda University
NCT02366689Phase 4Jun 1, 2014Colgate Palmolive
NCT02194621Phase 4Jan 1, 2014Colgate Palmolive
NCT03241407N/AJul 1, 2013Sao Paulo State University
NCT03145610N/AJun 1, 2013Sao Paulo State University
NCT01799226N/AMar 31, 2013University of Michigan
NCT01457859Phase 4Oct 1, 2011Technion University
NCT01220700N/ASep 30, 2010University of Oulu
NCT03191721Phase 3Jun 30, 2010Colgate Palmolive, Universidade Estadual de Maringá, University of Guarulhos (UNG)
NCT01019447Phase 4Nov 30, 2009Cairo University
NCT00762528Phase 4Feb 1, 2009Colgate Palmolive
NCT00763269Phase 3Sep 1, 2008Colgate Palmolive, University of Puerto Rico
Showing 20 of 44 trials
Page 1 / 3

Organizations

Research & Development (24)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Colgate PalmoliveFor profit323132000
Al Safwa HospitalAcademic/Hospital2012020
Cairo UniversityAcademic/Hospital2112009
ClinAmygateFor profit2212020
Misr University for Science and TechnologyAcademic/Hospital2012020
Sao Paulo State UniversityAcademic/Hospital2212013
University of OtagoAcademic/Hospital2012006
Al Zohour HospitalAcademic/Hospital1012020
Ben Arous Hospital, Tunis, TunisiaAcademic/Hospital1012020
Centro Ortopedico y Quirurgico del PieAcademic/Hospital1112020
Loma Linda UniversityAcademic/Hospital1012014
Minia UniversityAcademic/Hospital1012020
MSKMC Univeristy HospitalAcademic/Hospital1012020
Shahid Beheshti University of Medical SciencesAcademic/Hospital1012016
Shiraz UniversityAcademic/Hospital1112016
Technion UniversityAcademic/Hospital1112011
Tunis UniversityAcademic/Hospital1112020
Universidad Complutense de MadridAcademic/Hospital1012020
Universidade Estadual de MaringáAcademic/Hospital1012010
University of CampinasAcademic/Hospital1112016
24 organizations
Page 1 / 2

Marketing (2)

OrganizationOrg typeRelationshipDate
Colgate PalmoliveFor profitNDA2Jul 11, 1997
Colgate PalmoliveFor profitNDAJul 11, 1997